This transcript has been edited for clarity. Anne Cross, MD: Hello. I am Dr Anne Cross and welcome to Medscape's InDiscussion series on multiple sclerosis (MS). Today we'll be discussing cognitive ...
A recent neuropsychological evaluation diagnosis impugned several controversial theories about anesthesia and cognitive decline. As a medicinal therapy to relieve pain and brain dysfunction, ...
Studying the possible association between AI and cognitive dysfunction has accelerated over the past 7 years. A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in ...
Although there is a short-term risk of postoperative cognitive dysfunction after catheter ablation for atrial fibrillation (AF), it seems to resolve by 1 year, according to the results of a small ...
Post-COVID-19 condition (PCC) involves persistent symptoms like fatigue and cognitive dysfunction, affecting 8.4% of US adults. A randomized clinical trial showed cognitive and behavioral ...
YONGIN, South Korea--(BUSINESS WIRE)--GNT Pharma today announced the Korea Animal and Plant Quarantine Agency (APQA) has approved the New Drug Application for GedaCure®, a chewable tablet of ...
People with dementia have protein build-up in astrocytes that may trigger abnormal antiviral activity and memory loss, according to a preclinical study by a team of Weill Cornell Medicine ...
Many people with long Covid report neurological symptoms. A new study has uncovered potential clues as to why this happens to some people. Damage to brain cells and cognitive dysfunction can occur ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback